UK markets close in 5 hours 11 minutes

Moleculin Biotech, Inc. (0K2H.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
5.15+0.72 (+16.25%)
As of 05:19PM BST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.85
52-week change 3-30.39%
S&P500 52-week change 323.10%
52-week high 31.62
52-week low 30.00
50-day moving average 30.60
200-day moving average 30.65

Share statistics

Avg vol (3-month) 31.82k
Avg vol (10-day) 31.68k
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 81.93M
% held by insiders 14.65%
% held by institutions 115.42%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 20.066667:1
Last split date 322 Mar 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-38.73%
Return on equity (ttm)-76.07%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -29.5M
Net income avi to common (ttm)-29.77M
Diluted EPS (ttm)-0.64
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)23.55M
Total cash per share (mrq)10.57
Total debt (mrq)574k
Total debt/equity (mrq)2.20%
Current ratio (mrq)3.86
Book value per share (mrq)11.70

Cash flow statement

Operating cash flow (ttm)-24.1M
Levered free cash flow (ttm)-14.6M